🔎 Trials Near Me

Beranda › Gangguan Depresi Mayor › Pennsylvania › Philadelphia

Uji klinis Gangguan Depresi Mayor di Philadelphia, PA

23 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Philadelphia, Philadelphia
  • Flourish Research Philadelphia, Philadelphia
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06793397

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Menerima pesertaFase 3
  • Adams Clinical Philadelphia, Philadelphia
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07412756

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Philadelphia, Philadelphia
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • Suburban Research Associates, West Chester · 24 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300

Precision Depression Adalimumab Trial

Menerima pesertaFase 2
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845604

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Menerima pesertaFase 3
  • University of Pennsylvania - Perelman School of Medicine, Philadelphia
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Menerima pesertaFase 3
  • University of Pennsylvania, Philadelphia
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06559306

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

Menerima pesertaFase awal 1
  • University of Pennsylvania, Philadelphia
Usia 25 hingga 65 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06788249

Decoding and Modulating Affective Brain States

Menerima pesertaMenyebutkan pembayaran untuk peserta
  • University of Pennsylvania, Philadelphia
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT05437705

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Media · 12 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Menerima peserta
  • Pennsylvania Hospital, Philadelphia
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Media · 12 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07300969

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

Menerima pesertaFase 3
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07226232

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06963021

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical - Philadelphia, Philadelphia
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Menerima pesertaFase 2
  • Adams Clinical, Philadelphia
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07196501

Triage Survey for Psychiatry Research Eligibility

Menerima pesertaStudi observasional
  • Adams Clinical, Philadelphia, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05800925

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Menerima pesertaFase 2
  • University of Pennsylvania, Philadelphia
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830

Taking Action for College Students

Menerima peserta
  • Temple University, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Des 2025 · NCT06700902

Neurofeedback to Treat Depression - 2

Menerima peserta
  • Center for Neuromodulation in Depression and Stress, Philadelphia
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 4 Des 2025 · NCT07159061

Study of ALTO-300 in MDD

Menerima pesertaFase 2
  • Site 350, Media · 12 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05922878

Uji klinis Gangguan Depresi Mayor di kota lain

Studi lain di Philadelphia

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.